It seems to be that NNVC doesn't want to start tox studies until they can raise more money. But they can only raise money by selling more shares. So they want the share price to go up first. But the share price will do nothing but drift down until tox studies are completed and human trials can begin. Round peg, meet square hole.
I have always felt that the biggest risk with NNVC is financial, not scientific. Nothing in the latest release has changed my mind on that.
News 
Market Data 
Discover 
